SB820 creates the Whistleblower Protection Fund Act and establishes a special revenue fund in the State Treasury to support public awareness efforts encouraging whistleblower reports. The bill is aimed at clinical inpatient medical treatment centers, office-based medication-assisted treatment programs, and opioid treatment programs, with the stated purpose of promoting ethical practices and protecting patient care and safety by encouraging reporting of unethical or illegal conduct without fear of retaliation.
The bill directs the Office of the Inspector General to administer the fund, manage its use, and develop a public awareness campaign that may include advertisements, informational materials, social media outreach, and other promotional efforts. The fund may receive legislative appropriations, donations, and grants, and any year-end balance remains in the fund rather than reverting to the General Revenue Fund. The bill also requires the Inspector General to accept whistleblower reports in a form established by the office and to report annually to the Joint Standing Committee on Health on campaign activities, the number of reports received, and the outcomes of those reports.
Impact
SB820 adds a new article to the West Virginia Code, creating a dedicated special revenue fund and assigning the Office of the Inspector General new administrative and reporting responsibilities. It does not directly create new penalties or substantive whistleblower rights in the text provided, but it supports reporting infrastructure and public outreach for facilities regulated under §16B-13-2, especially addiction treatment and opioid treatment settings. The bill affects state budgeting by allowing the fund to retain balances and accept multiple funding sources, and it creates an ongoing reporting obligation to legislative oversight committees.
Sentiment
The available voting history shows strong bipartisan or at least unanimous support in the Senate, with the bill passing 31-0 and also passing effective from passage 31-0. No committee transcript excerpts were provided, so there is no recorded debate to indicate opposition or concern in the materials supplied. Overall, the bill appears to have been received favorably as a patient-safety and accountability measure.
Contention
No specific points of contention are documented in the provided committee materials. Based on the bill text, any potential areas of concern would likely center on the use of state funds for advertising and outreach, the scope of the Inspector General’s administrative role, and whether the bill’s approach sufficiently protects whistleblowers while ensuring reports are handled effectively. However, the recorded vote suggests those issues did not generate visible opposition in the Senate.